Experience of treatment of prosthetic valve endocarditis: a retrospective single-center cross-sectional study
- PMID: 30066725
- PMCID: PMC9881692
- DOI: 10.1590/1516-3180.2018.031150418
Experience of treatment of prosthetic valve endocarditis: a retrospective single-center cross-sectional study
Abstract
Background: The aim of this study was to describe the experience of treatment of early prosthetic valve endocarditis at a heart center.
Design and setting: Retrospective single-center study on data collected from electronic medical records covering the period from January 2009 to December 2015.
Methods: Over the study period, 1,557 consecutive valve operations were performed on adult patients. The study population comprised 32 patients (2%) who were diagnosed with prosthetic valve endocarditis within 12 months after the index surgery. Medical records were retrieved from electronic hospital records, retrospectively. Descriptive clinical, echocardiographic, microbiological and treatment-type data were used. Risk factors for early mortality were studied through univariate and multivariate analyses.
Results: The main clinical manifestation of infective endocarditis was fever, and this was present in all patients. Most of the prostheses were affected in the aortic position (40.6% of cases). The most commonly cultured microorganisms were Staphylococcus epidermidis and Staphylococcus aureus. Twenty-six patients (81.3%) underwent surgical treatment and six (18.7%) underwent exclusive clinical treatment. The prevalence of postoperative complications was 31.3% and hospital mortality occurred in seven cases (21.9%). The mortality rate was 50% among the patients who underwent medical treatment and 15.4% among those who underwent surgery. There were no independent risk factors for mortality.
Conclusion: Prosthetic valve endocarditis is an infrequent complication of valve replacement. Surgical treatment has mortality rates compatible with the severity of patients' conditions. Surgical indication should not be delayed when clinical treatment has been ineffective.
Conflict of interest statement
Similar articles
-
Surgical management of Staphylococcus capitis prosthetic valve infective endocarditis: Retrospective review of a 10-year single center experience and review of the literature.J Infect Public Health. 2020 Nov;13(11):1705-1709. doi: 10.1016/j.jiph.2020.09.010. Epub 2020 Oct 11. J Infect Public Health. 2020. PMID: 33055006 Review.
-
Surgical management of infective endocarditis: an analysis of early and late outcomes.Eur J Cardiothorac Surg. 2015 May;47(5):826-32. doi: 10.1093/ejcts/ezu281. Epub 2014 Jul 15. Eur J Cardiothorac Surg. 2015. PMID: 25027271
-
Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.Heart. 2005 Feb;91(2):e10. doi: 10.1136/hrt.2004.040659. Heart. 2005. PMID: 15657200 Free PMC article.
-
[Prosthetic valve endocarditis].Rev Esp Cardiol. 1998;51 Suppl 2:58-63. Rev Esp Cardiol. 1998. PMID: 9658950 Review. Spanish.
-
Prosthetic valve endocarditis. Experience with porcine bioprostheses.J Thorac Cardiovasc Surg. 1993 Mar;105(3):428-34. J Thorac Cardiovasc Surg. 1993. PMID: 8445921
Cited by
-
Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review.J Am Heart Assoc. 2020 Aug 18;9(16):e017347. doi: 10.1161/JAHA.120.017347. Epub 2020 Aug 8. J Am Heart Assoc. 2020. PMID: 32772772 Free PMC article.
References
-
- Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1–52. doi: 10.1161/CIR.0000000000000296. - DOI - PubMed
-
- Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease) Circulation. 2006;(114):e84–e231. doi: 10.1161/CIRCULATIONAHA.106.176857. Available from: http://circ.ahajournals.org/content/114/5/e84 . Accessed in 2018 (21 May) - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical